FITC-Labeled Monoclonal Anti-FMC63 Antibody, Mouse IgG1 (Y45)DMF

製品番号/仕様
価格
数量
FM3-FY45-25tests
$340.00
FM3-FY45-200tests
$2110.00
ETA of in-stock products:2 business days
総アイテム数 製品金額$ 0

製品詳細

  • Source

    Monoclonal Anti-FMC63 Antibody, Mouse IgG1 (Y45) is a neutralizing mouse monoclonal antibody produced from hybridoma.

  • Antibody Type

    Hybridoma Monoclonal

  • Clone

    Y45

  • Isotype

    Mouse IgG1, Kappa

  • Host Species

    Mouse

  • Immunogen

    Recombinant FMC63 scFv expressed in HEK293 cells

  • Conjugate

    FITC

    Excitation source: 488 nm spectral line, argon-ion laser

    Excitation Wavelength: 488 nm

    Emission Wavelength: 535 nm

  • Specificity

    This antibody specifically recognizes the FMC63 scFv antigen-recognition domain in FMC63-derived CARs.

  • Application

    Flow Cytometry (Evaluation of Anti-CD19 (FMC63 scFv) CAR Expression).

  • Recommended Dilution

    1:50

  • Isotype Control

    The isotype control is sold separately; please refer to Cat. No. DNP-FM1A1 for product information.

  • Form

    Lyophilized

  • Formulation

    Lyophilized from a 0.22 μm-filtered solution in PBS (pH 7.4) containing 0.5% BSA, with trehalose as protectant.

    Please contact us for customized product forms or formulations.

  • Reconstitution

    Please refer to the Certificate of Analysis (CoA) for specific instructions.

  • Shipping

    Lyophilized product is shipped at ambient temperature.

  • Storage

    For long term storage, the product should be stored in a lyophilized state at -20°C or lower.

    Please protect from light and avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 24 months in lyophilized state;
    2. -70°C for 12 months under sterile conditions after reconstitution.
  • Notices

    Product Specific Notices: For research use only.

  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

お客様はこちらも閲覧

データ表示

  • Bioactivity-FACS

     FMC63 FACS

    2e5 of Anti-CD19 CAR-293 cells were stained with 100 μL of 1:50 dilution (2 μL stock solution in 100 μL FACS buffer) FITC-Labeled Monoclonal Anti-FMC63 Antibody, Mouse IgG1 (Y45) (Cat. No. FM3-FY45) and isotype control respectively. FITC signal was used to evaluate the binding activity (QC tested).

    Protocol
  •  FMC63 FACS

    Non-specificity of FITC-Labeled Monoclonal Anti-FMC63 Antibody, Mouse IgG1 (Y45) (Cat. No. FM3-FY45) binding to CD3+ cells present in human PBMC. Human PBMCs were simultaneously stained with PE-labeled anti-CD3 antibody and FITC-Labeled Monoclonal Anti-FMC63 Antibody, Mouse IgG1 (Y45) (2 μL of the antibody stock solution corresponds to labeling of 5e5 cells in a final volume of 100 µL), washed and then analyzed with FACS. Both PE and FITC positive signals was used to evaluate the non-specific binding activity to human CD3+ cells (QC tested).

    Protocol

ユーザーレビュー
コメントを投稿

  • A***l2023-05-19
    いいね
    My team purchased the FITC-conjugated Anti-FMC63 antibody (FM3-FY45) to characterize a CAR-T cell line that we had developed. We used the antibody in our flow cytometry experiment, and we saw virtually no background signal in our negative control samples (0% and 1% FITC readout). We did, however, get beautiful results for our CAR-T cell line samples and were able to confirm successful transduction. The instructions for use in the CoA were very clear, and the recommended concentration was sufficient for our purposes. I am very interested in revisiting ACRO Biosystems for more antibody purchases in the future.
  • C***ó2021-09-28
    いいね
    We purchase the anti FMC63 to detect Chimeric antigen receptor (CAR) cells in patients treated with an academic CAR for lymphoma. We used the antibody to detect by flow cytometry the cells that express the CAR and the persistence of our modified T cells. We are extremely satisfied with the performance of the antibodies. We are developing new CAR and for sure we will use the antibodies from Acrobiosystems.
  • L***a2021-08-25
    いいね
    We are a CAR-T therapy research group and we use FITC anti-FMC63 and FITC-Labeled Human CD19 protein to detect CAR19 cells both in patient blood and in vitro cultures by flow cytometry. The results obtained so far with both reagents are reliable and reproducible, with a clear and easy detection of positive population even when reagents are directly incubated with blood samples.

バックグランド

FMC63 is an IgG2a mouse monoclonal antibody specific for CD19, which is a target for the immunotherapy of B lineage leukaemias and lymphomas. FMC63 scFv is the most commonly used ectodomain component of CD19-specific CARs. So far, most of reported CART19 trials contain the anti-CD19 scFv derived from FMC63, including the two FDA-approved CARs Kymriah and Yescarta.

最新の進展

 
お問い合わせ
医薬品候補ライセンス
他の関連情報
  • 製品情報
  • 製品詳細
  • お客様はこちらも閲覧
  • データ表示
  • ユーザーレビュー
  • 背景
お問い合わせ

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8